MedTrace Logo

Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)

NCT02428842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 419

Last updated 2023-01-20

No results posted yet for this study

Summary

Prospective Multicentric European trial for Cervical cancer, not previously treated, with tumour biopsies, and blood collection for molecular analysis at predetermined time points.

Conditions

Interventions

PROCEDURE

Tumor biopsies

Tumor biopsies will be performed before and after treatment.

PROCEDURE

Blood sampling

Blood sampling will be performed before and after treatment.

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-24
Primary Completion
2018-11-21
Completion
2020-10-20

Countries

  • France
  • Germany
  • Netherlands
  • Romania
  • Serbia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428842 on ClinicalTrials.gov